Rare Diseases Society of Chinese Research Hospital Association, China Alliance for Rare Disease, Beijing Society of Rare Disease Clinical Care and Accessibility, Gitelman Syndrome Consensus Working Group. Expert Consensus for the Diagnosis and Treatment of Gitelman Syndrome in China (2021)[J]. Journal of Rare Diseases, 2022, 1(1): 56-67. DOI: 10.12376/j.issn.2097-0501.2022.01.010
Citation: Rare Diseases Society of Chinese Research Hospital Association, China Alliance for Rare Disease, Beijing Society of Rare Disease Clinical Care and Accessibility, Gitelman Syndrome Consensus Working Group. Expert Consensus for the Diagnosis and Treatment of Gitelman Syndrome in China (2021)[J]. Journal of Rare Diseases, 2022, 1(1): 56-67. DOI: 10.12376/j.issn.2097-0501.2022.01.010
shu
    Abstract
  • In recent years, research on the clinical phenotypes, new classifications, modified functional tests, biomarkers and management experience for patients with Gitelman syndrome (GS)has made a lot of progress in China. Based on evidence-based medicine, this consensus summarizes aspects related to GS, including clinical manifestations and classification, diagnosis, treatment strategies, and management of chronic complica-tions and comorbidity. This consensus provides an important reference for the diagnosis and treatment of GS.
    • FullText(HTML)
  • loading
    • References (77)
    • Relative Articles
  • Supplements (0)

Catalog

    RSS Email alert

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return